Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
This study is ongoing, but not recruiting participants.
Study NCT00010270 Information provided by National Cancer Institute (NCI)
First Received: February 2, 2001 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer
Additional conditions recognized in this trial
Adenocarcinoma
Colorectal Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Pancreatic Neoplasms
Rectal Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Rectal Diseases
Stomach Diseases
Interventions listed in this trial
LMB-9 immunotoxin
Additional drug interventions recognized in this trial
Immunotoxins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University Hospital Freiburg
National Cancer Institute (NCI)
Back to top of Main Content
